GlobalRPh Renal Dosing Masterv6.6
Source review / handoff

Anastrozole tablets

One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.

Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.

Share or print this source review

1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.

Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.

Clinical context remains essential

Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.

Check source scope before reading a dose

Renal Drug Handbook, fifth edition - Anastrozole tablets

Product / population
Historical renal/RRT cross-check for the named ingredient; not a current U.S. prescribing instruction.
Renal method
Book table headings say GFR (mL/min); the preface states adjustment information is based on Cockcroft-Gault CrCl, not indexed eGFR. Do not substitute methods.
Source revision
Fifth edition, 2019
Retrieved
2026-09-05
Local review status
Historical source, separately displayed. Renal tables were read with page-image inspection.
Handbook

Renal Drug Handbook, fifth edition - Anastrozole tablets

UK Renal Pharmacy Group / CRC Press · Historical renal/RRT cross-check for the named ingredient; not a current U.S. prescribing instruction.

Renal method: Book table headings say GFR (mL/min); the preface states adjustment information is based on Cockcroft-Gault CrCl, not indexed eGFR. Do not substitute methods.
Source date: Fifth edition, 2019
Retrieved: 2026-09-05

Historical source, separately displayed. Renal tables were read with page-image inspection.

Historical renal and dialysis observations

The book retains standard dosing in all three renal bands and its listed dialysis modalities. Its commentary explicitly contrasts U.S. no-reduction advice with an older UK recommendation to avoid use below 20 mL/min.

RDM31-anastrozole-book · Source locator: Dose in renal impairment; renal replacement therapies; Other information

Source-specific limits

That UK restriction is a historical statement in the 2019 book, not a claim about current UK labeling. Do not import it into the U.S. dose rule.

Source identity and provenance
Retrieved
2026-09-05
Handbook page
Printed page(s) 71; PDF page(s) 90
Renal-function method
Book table headings say GFR (mL/min); the preface states adjustment information is based on Cockcroft-Gault CrCl, not indexed eGFR. Do not substitute methods.
Source date/version
Fifth edition, 2019
U.S. product identity basis
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=acbfaaa9-503c-4691-9828-76a7146ed6de
Hash meaning
SHA-256 identifies the local paraphrase; the source PDF is not redistributed.
Local summary SHA-256
8a83f954df7fba60ffd610d56bc8dc1094cae61be2dda9a809aa1155e2d342c9

Document the clinical decision separately

This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.

GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.

Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=anastrozole&s1=RDM31-book-anastrozole&h1=b7690af14928b868f274655222a010808eee066fa967c84a62ea626b0caeaf60